Application 218820

Type
NDA
Sponsor
NEUROCRINE

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001CRENESSITYCRINECERFONTSOLUTION;ORAL50MG/MLYesYes

Documents

DocumentSubmission typeDate
80833ORIG 2025-01-10
80598ORIG 2024-12-16
80575ORIG 2024-12-13